Apotex Health Corp. (TSX:APTX)
Canada · Delayed Price · Currency is CAD 39.67
+2.13 (5.67%)
At close: Jul 21, 2026
Apotex Health Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Apotex Health stock has a consensus rating of "Buy" and an average price target of $40.69. The average 1-year stock price forecast is 2.57% higher than the current stock price, while the lowest is $36.00 (-9.25%) and the highest is $43.00 (+8.39%).
Price Target: $40.69 (+2.57%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Apotex Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '26 |
|---|---|
| Strong Buy | 5 |
| Buy | 6 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Initiates $42.00 | Buy | Initiates | $42.00 | +5.87% | Jul 13, 2026 |
| Bloom Burton | Bloom Burton | Buy Initiates $40.00 | Buy | Initiates | $40.00 | +0.83% | Jul 7, 2026 |
| Raymond James | Raymond James | Buy Initiates $36.00 | Buy | Initiates | $36.00 | -9.25% | Jul 6, 2026 |
| National Bank | National Bank | Buy Initiates $43.00 | Buy | Initiates | $43.00 | +8.39% | Jul 6, 2026 |
| Jefferies | Jefferies | Buy Initiates $40.00 | Buy | Initiates | $40.00 | +0.83% | Jul 6, 2026 |
Financial Forecast
Revenue This Year
3.39B
from 3.49B
Decreased by -2.84%
Revenue Next Year
3.69B
from 3.39B
Increased by 8.68%
EPS This Year
2.01
EPS Next Year
2.33
from 2.01
Increased by 15.86%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.